SARS-CoV-2 Mpro-IN-17 (compound S5-28) is an orally active and noncovalent SARS-CoV-2 Mpro inhibitor with the EC50 of 1.35 µM. SARS-CoV-2 Mpro-IN-17 can be used for study of COVID-19[1].
Molecular Weight:
448.74
Formula:
C20H19BrClN3O2
Target:
SARS-CoV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted